DK116286A - Antibiotisk aktiv forbindelse betegnet cl-1577-b4, fremgangsmaade til dens fremstilling og dens anvendelse - Google Patents

Antibiotisk aktiv forbindelse betegnet cl-1577-b4, fremgangsmaade til dens fremstilling og dens anvendelse Download PDF

Info

Publication number
DK116286A
DK116286A DK116286A DK116286A DK116286A DK 116286 A DK116286 A DK 116286A DK 116286 A DK116286 A DK 116286A DK 116286 A DK116286 A DK 116286A DK 116286 A DK116286 A DK 116286A
Authority
DK
Denmark
Prior art keywords
compound
activity against
procedure
preparation
active compound
Prior art date
Application number
DK116286A
Other languages
English (en)
Other versions
DK116286D0 (da
Inventor
John H Wilton
James C French
Gerard C Hokanson
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK116286D0 publication Critical patent/DK116286D0/da
Publication of DK116286A publication Critical patent/DK116286A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacture Of Tobacco Products (AREA)
DK116286A 1985-03-15 1986-03-13 Antibiotisk aktiv forbindelse betegnet cl-1577-b4, fremgangsmaade til dens fremstilling og dens anvendelse DK116286A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/712,294 US4594248A (en) 1985-03-15 1985-03-15 CL-1577-B4 compound, its production and use

Publications (2)

Publication Number Publication Date
DK116286D0 DK116286D0 (da) 1986-03-13
DK116286A true DK116286A (da) 1986-09-16

Family

ID=24861526

Family Applications (1)

Application Number Title Priority Date Filing Date
DK116286A DK116286A (da) 1985-03-15 1986-03-13 Antibiotisk aktiv forbindelse betegnet cl-1577-b4, fremgangsmaade til dens fremstilling og dens anvendelse

Country Status (10)

Country Link
US (2) US4594248A (da)
EP (1) EP0194784B1 (da)
JP (1) JPH0689012B2 (da)
AT (1) ATE72565T1 (da)
AU (1) AU589943B2 (da)
CA (1) CA1253820A (da)
DE (1) DE3683860D1 (da)
DK (1) DK116286A (da)
ES (1) ES8706162A1 (da)
ZA (1) ZA861052B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539203A (en) * 1984-11-13 1985-09-03 Warner-Lambert Company CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use
US4921700A (en) * 1985-08-27 1990-05-01 Bristol-Myers Company BBM-1675c and d antitumor antibiotics
US4939244A (en) * 1987-01-30 1990-07-03 American Cyanamid Company Pseudoaglycones of LL-E33288 antibiotics
US4837206A (en) * 1987-04-29 1989-06-06 Bristol-Myers Company Esperamicin derivatives
US4952572A (en) * 1988-06-10 1990-08-28 Bristol-Myers Company BU-3420T antifungal antibiotic
US4916065A (en) * 1988-06-10 1990-04-10 Bristol-Myers Company BU-3420T Antitumor antibiotic
US5086045A (en) * 1989-03-15 1992-02-04 Bristol-Myers Squibb Company Antitumor antibiotic
US5028536A (en) * 1989-03-15 1991-07-02 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41339
US5116845A (en) * 1990-05-04 1992-05-26 Bristol-Myers Company BU-3420T antitumor antibiotic
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335108A (en) * 1980-08-25 1982-06-15 The Upjohn Company Paulomycin A and B and preparation thereof
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
US4539203A (en) * 1984-11-13 1985-09-03 Warner-Lambert Company CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use

Also Published As

Publication number Publication date
ZA861052B (en) 1987-09-30
AU589943B2 (en) 1989-10-26
ES553051A0 (es) 1987-05-16
US4661353A (en) 1987-04-28
EP0194784A2 (en) 1986-09-17
EP0194784B1 (en) 1992-02-12
ES8706162A1 (es) 1987-05-16
ATE72565T1 (de) 1992-02-15
DK116286D0 (da) 1986-03-13
DE3683860D1 (de) 1992-03-26
JPS61216692A (ja) 1986-09-26
JPH0689012B2 (ja) 1994-11-09
US4594248A (en) 1986-06-10
EP0194784A3 (en) 1987-12-09
CA1253820A (en) 1989-05-09
AU5337386A (en) 1986-09-18

Similar Documents

Publication Publication Date Title
BG44205A3 (en) Method for preparing of antibiotic s541
GB1491266A (en) Anti-tumor antibiotics aclacinomycins a and b
IE872438L (en) 23-oxo(keto) and 23-imino derivatives of ll-f28249 compounds
DK116286D0 (da) Antibiotisk aktiv forbindelse betegnet cl-1577-b4, fremgangsmaade til dens fremstilling og dens anvendelse
EP0315147A3 (en) New antibiotics, benanomicins a and b and dexylosylbenanomicin b, and production and uses thereof
DK520485D0 (da) Cl-1577d og cl-1577e antibiotiske/antitumor forbindelse, deres fremstilling og anvendelse
IE37892L (en) Antibiotic a.2315.
ES8801703A1 (es) Un nuevo procedimiento para producir el (los) antibiotico (s) macrolido (s) 4s-02930 k-d-e o-h.
AU7827987A (en) Spiro derivatives
ES8102188A1 (es) Procedimiento para la obtencion de derivados de la rifamici-na-s
EP0139457A3 (en) An antibiotic compound and its production
PH21674A (en) A biologically pure culture of the microorganism streptomyces hygroscopic atcc 39205
HUT50360A (en) Process for producing antibiotic uk-61689 by microbiological way and pharmaceutical composition comprising the active ingredient and mycelium
AU571956B2 (en) 3-azinomethyl rifamycins
IE860279L (en) (oxy) difficol from b. subtilis
GB1387769A (en) Butenoic acid derivatives and a process for the manufacture thereof
ATE48843T1 (de) 2-amino-1,9-dihydro-6h-purin-6-one-7-oxyde, die pharmazeutisch vertraeglichen salze und ein verfahren zu ihrer herstellung.
IE880621L (en) Mono- and diepoxide derivatives of 23-deoxy-LL-F28249¹compounds
JPS548792A (en) Novel preparation of ribostamycin
EP0004735A3 (en) Antibiotics designated as bm 782 alpha 1, bm 782 alpha 2 and bm 782 alpha 1a, process for their preparation and pharmaceutical compositions containing them
CA2010768A1 (en) Acidic polycyclic ether antibiotic
ES8403907A1 (es) Un procedimiento para la produccion de nuevos derivados de los antibio-oa-6129, ca-6129 b1 y ca-6129b2

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment